The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Role of p53 in Neurodegenerative Diseases
Abstract
Background: p53 plays an important role in many areas of cellular physiology and biology, ranging from cellular development and differentiation to cell cycle arrest and apoptosis. Many of its functions are attributed to its role in assuring proper cellular division. However, since the establishment of its role in cell cycle arrest, damage repair, and apoptosis (thus also establishing its importance in cancer development), numerous reports have demonstrated additional functions of p53 in various cells. In particular, p53 appears to have important functions as it relates to neurodegeneration and synaptic plasticity. Objective: In this review, we will address p53 functions as it relates to various neurodegenerative diseases, mainly its implications in the development of HIV-associated neurocognitive disorders. Conclusion: p53 plays a pivotal role in the development of neurodegenerative diseases through its interaction with cellular factors, viral factors, and/or small RNAs that have the ability to promote the development of these diseases. Hence, inhibition of p53 may present an ideal target to restore neuronal functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 is considered a pathogenic factor in NDDs.200”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury
Cho, D.-H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., & Lipton, S. A. (2009) · Science · doi:10.1126/science.1171091 · Cited by 1,092
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
Trushina, E., Dyer, R. B., Badger, J. D., Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8195-8209.2004 · Cited by 520
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Mitochondrial alterations in Alzheimer's disease
Baloyannis, S. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9204 · Cited by 318
Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease
Ohyagi, Y., Asahara, H., Chui, D.-H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2637fje · Cited by 281
Changes of p53 in the Brains of Patients with Alzheimer's Disease
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6301 · Cited by 185
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches
Kaul, M. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328329cf3c · Cited by 103
GSK3 and p53 - is there a link in Alzheimer's disease?
Proctor, C. J., & Gray, D. A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-7 · Cited by 80
Research works printed but not linked: 143
- 10.1016%2Fj.cell.2008.05.020 · DOI · Paper page
- 10.5115%2Facb.2010.43.3.179 · DOI
- 10.1152%2Fajpcell.00248.2010 · DOI
- 10.1074%2Fjbc.M110.171975 · DOI · Paper page
- 10.1007%2Fs11033-010-0099-x · DOI
- 10.1073%2Fpnas.0901864106 · DOI
- 10.1016%2FS0092-8674%2800%2980521-8 · DOI · Paper page
- 10.1016%2Fj.molcel.2007.11.036 · DOI
- 10.1073%2Fpnas.96.26.14973 · DOI · Paper page
- 10.1006%2Fexnr.1998.6958 · DOI · Paper page
- 10.1093%2Fbrain%2Fawm148 · DOI
- 10.1128%2FJVI.02094-07 · DOI
- 10.1371%2Fjournal.pone.0003731 · DOI
- 10.1111%2Fj.1471-4159.2007.04609.x · DOI
- 10.1016%2FS0165-6147%2803%2900125-1 · DOI
- 10.1196%2Fannals.1299.004 · DOI
- 10.1016%2Fj.bbrc.2005.03.149 · DOI · Paper page
- 10.1016%2Fj.brainres.2009.11.078 · DOI
- 10.1007%2Fs11481-007-9095-x · DOI
- 10.1074%2Fjbc.M603950200 · DOI
- 10.1006%2Fexnr.2000.7489 · DOI · Paper page
- 10.1111%2Fj.1600-079X.1999.tb00619.x · DOI
- 10.1177%2F1533317507302447 · DOI
- 10.1242%2Fjcs.03468 · DOI
- 10.1038%2Fcdd.2009.216 · DOI · Paper page
- 10.1038%2Fsj.emboj.7601292 · DOI · Paper page
- 10.1083%2Fjcb.200512059 · DOI · Paper page
- 10.1523%2FJNEUROSCI.4416-09.2009 · DOI
- 10.1111%2Fj.1432-0436.2007.00261.x · DOI
- 10.1385%2FNMM%3A3%3A3%3A159 · DOI
- 10.1016%2Fj.nbd.2009.12.015 · DOI
- 10.1212%2F01.wnl.0000278457.55877.eb · doi:10.1212/01.wnl.0000278457.55877.eb
- 10.1212%2F01.wnl.0000260610.79853.47 · DOI
- 10.1080%2F13550280600716604 · DOI
- 10.1016%2Fj.neulet.2004.02.012 · DOI
- 10.1016%2FS0002-9440%2810%2962044-5 · DOI
- 10.1523%2FJNEUROSCI.5522-06.2007 · DOI
- 10.1212%2FWNL.0b013e3181f4d5bb · DOI · Paper page
- 10.3109%2F13550280903131915 · DOI · Paper page
- 10.1038%2Fnm1007-1138 · DOI
- 10.1016%2Fj.chom.2011.02.005 · DOI
- 10.1189%2Fjlb.0409264 · DOI
- 10.1128%2FJVI.00591-06 · DOI · Paper page
- 10.1128%2FJVI.00124-08 · DOI
- 10.1128%2FJVI.76.2.707-716.2002 · DOI · Paper page
- 10.1186%2F1742-4690-6-51 · DOI · Paper page
- 10.1084%2Fjem.192.8.1081 · DOI · Paper page
- 10.1038%2Fsj.cdd.4400748 · DOI
- 10.1111%2Fj.1365-2990.1997.tb01208.x · doi:10.1111/j.1365-2990.1997.tb01208.x
- 10.1007%2Fs11481-008-9110-x · DOI
- 10.1007%2Fs004010051113 · doi:10.1007/s004010051113
- 10.1111%2Fj.1750-3639.2003.tb00014.x · DOI · Paper page
- 10.1371%2Fjournal.pone.0016148 · DOI
- 10.1038%2F345084a0 · DOI · Paper page
- 10.1089%2Faid.1988.4.319 · DOI
- 10.2174%2F157016209787581508 · doi:10.2174/157016209787581508
- 10.1046%2Fj.1365-2362.2002.01029.x · DOI
- 10.1089%2Faid.2009.0170 · DOI · Paper page
- 10.1038%2Fsj.onc.1207846 · DOI
- 10.1038%2Fsj.onc.1204956 · DOI
- 10.1074%2Fjbc.273.32.20052 · DOI
- 10.1089%2F104454904773819833 · DOI
- 10.1002%2Fjcp.20698 · DOI
- 10.1189%2Fjlb.0306189 · DOI
- 10.1186%2F1743-422X-6-114 · DOI
- 10.4161%2Fcc.7.17.6450 · DOI
- 10.1038%2Fsj.cdd.4401584 · DOI · Paper page
- 10.1128%2FJVI.76.6.2692-2702.2002 · DOI
- 10.1016%2Fj.molcel.2007.05.017 · DOI · Paper page
- 10.4161%2Fcc.6.13.4436 · DOI · Paper page
- 10.1186%2F1471-2164-11-514 · DOI
- 10.1073%2Fpnas.96.14.8212 · DOI · Paper page
- 10.1074%2Fjbc.M305870200 · DOI · Paper page
- 10.1002%2Fana.10729 · DOI
- 10.1016%2Fj.bbrc.2005.03.185 · DOI
- 10.1002%2Fana.410310402 · DOI · Paper page
- 10.1038%2Fnri1527 · DOI · Paper page
- 10.1523%2FJNEUROSCI.5387-10.2011 · DOI
- 10.1016%2Fj.ceca.2009.12.009 · DOI
- 10.1016%2Fj.nbd.2009.10.020 · DOI
- 10.1023%2FA%3A1021687810103 · DOI · Paper page
- 10.1007%2Fs11055-009-9141-7 · DOI
- 10.1111%2Fj.1471-4159.2007.05187.x · DOI
- 10.1097%2F00001756-199601310-00028 · DOI
- 10.1016%2FS0006-8993%2800%2901959-4 · DOI
- 10.1016%2Fj.neuroscience.2005.05.028 · DOI
- 10.1074%2Fjbc.M209381200 · doi:10.1074/jbc.m209381200
- 10.1089%2Fars.2010.3504 · DOI
- 10.1038%2Fsj.emboj.7601657 · DOI
- 10.1172%2FJCI30945 · DOI
- 10.1385%2FJMN%3A23%3A1-2%3A097 · DOI
- 10.1385%2FJMN%3A28%3A2%3A111 · DOI
- 10.1097%2FWAD.0b013e31815a9dec · DOI
- 10.1016%2FS0006-8993%2800%2902979-6 · DOI
- 10.1097%2F00005072-199701000-00009 · DOI · Paper page
- 10.1016%2FS0006-8993%2896%2901351-0 · DOI
- 10.1371%2Fjournal.pone.0006816 · DOI · Paper page
- 10.1016%2FS1097-2765%2803%2900050-9 · DOI · Paper page
- 10.1038%2Fncb1123 · DOI · Paper page
- 10.1074%2Fjbc.273.13.7770 · DOI · Paper page
- 10.1016%2Fj.cub.2005.10.041 · DOI · Paper page
- 10.1016%2Fj.nbd.2006.01.017 · DOI
- 10.1016%2Fj.molcel.2008.08.002 · DOI · Paper page
- 10.1111%2Fj.1749-6632.1997.tb48508.x · doi:10.1111/j.1749-6632.1997.tb48508.x
- 10.1111%2Fj.1749-6632.2009.04886.x · doi:10.1111/j.1749-6632.2009.04886.x
- 10.1016%2F0006-8993%2878%2990562-0 · DOI · Paper page
- 10.1007%2FBF00703200 · DOI
- 10.1126%2Fscience.3992249 · DOI · Paper page
- 10.1001%2Farchneur.1995.00540270110027 · DOI
- 10.1083%2Fjcb.143.3.777 · DOI · Paper page
- 10.1371%2Fjournal.pone.0008310 · DOI
- 10.1038%2Fcdd.2008.175 · DOI
- 10.1158%2F0008-5472.CAN-03-0846 · DOI · Paper page
- 10.1016%2Fj.tcb.2007.04.004 · DOI · Paper page
- 10.1016%2Fj.ceb.2009.12.006 · DOI
- 10.1111%2Fj.1471-4159.2009.06485.x · DOI
- 10.1038%2Fsj.mp.4002060 · DOI
- 10.1016%2Fj.neulet.2006.12.003 · DOI · Paper page
- 10.1074%2Fjbc.M509509200 · DOI
- 10.1038%2Fncb1981 · DOI · Paper page
- 10.1126%2Fscience.1077209 · DOI · Paper page
- 10.1074%2Fjbc.M707176200 · DOI · Paper page
- 10.1002%2Fana.20251 · DOI · Paper page
- 10.1038%2Fcdd.2009.28 · DOI · Paper page
- 10.1074%2Fjbc.M808515200 · DOI · Paper page
- 10.1074%2Fjbc.M508619200 · DOI
- 10.1074%2Fjbc.M207825200 · DOI · Paper page
- 10.1016%2FS1353-8020%2809%2970800-4 · DOI
- 10.1006%2Fnbdi.2002.0528 · DOI
- 10.1111%2Fj.1365-2990.1997.tb01326.x · doi:10.1111/j.1365-2990.1997.tb01326.x
- 10.1016%2FS0140-6736%2807%2960111-1 · DOI · Paper page
- 10.1093%2Fhmg%2F11.6.633 · DOI · Paper page
- 10.1074%2Fjbc.M109.093708 · DOI · Paper page
- 10.1016%2Fj.ymgme.2007.10.002 · DOI
- 10.1016%2Fj.nbd.2005.12.007 · DOI · Paper page
- 10.1002%2F1531-8249%28199901%2945%3A1%3C25%3A%3AAID-ART6%3E3.0.CO%3B2-E · doi:10.1002/1531-8249(199901)45:1<25::aid-art6>3.0.co;2-e
- 10.1016%2Fj.neuron.2005.06.005 · DOI · Paper page
- 10.1016%2Fj.nbd.2005.04.011 · DOI
- 10.1073%2Fpnas.100110097 · DOI · Paper page
- 10.1016%2Fj.nbd.2006.08.002 · DOI · Paper page
- 10.1002%2Fjnr.21881 · DOI
- 10.1038%2Fsj.onc.1209551 · DOI
- 10.1212%2FWNL.0b013e31820a0cfc · DOI · Paper page
Cited by
Inflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 300
Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Koylu, E., & Yalcin, A. (2014) · Free Radical Research · doi:10.3109/10715762.2013.857018 · Cited by 169
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Metadata
- Authors
- Chang, J. R., Ghafouri, M., Mukerjee, R., Bagashev, A., Chabrashvili, T., & Sawaya, B. E.
- Venue
- Neurodegenerative Diseases
- Publisher
- S. Karger AG
- Published
- 2011-10-28
- Volume
- 9
- Issue
- 2
- Pages
- 68-80
- ISSN
- 1660-2854
- 1660-2862
- Cited by
- 134
- References
- 26
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.